ALLM
ALLM (Calpain inhibitor II) is a potent inhibitor of calpain and cathepsin proteases. ALLM inhibits neuronal cell death and improves chronic neurological function after spinal cord injury (SCI) [1][2].
Product Specifications
CAS Number
110115-07-6
Product Name Alternative
Calpain inhibitor II
UNSPSC
12352211
Target
Cathepsin; Proteasome
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/allm.html
Purity
98.60
Solubility
DMSO : ≥ 20 mg/mL
Smiles
CSCC[C@@H](C=O)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC(C)=O)=O)=O
Molecular Formula
C19H35N3O4S
Molecular Weight
401.56
References & Citations
[1]Stangl V, et al. Long-term up-regulation of eNOS and improvement of endothelial function by inhibition of the ubiquitin-proteasome pathway. FASEB J. 2004 Feb;18 (2) :272-9.|[2]Arataki S, et al. Calpain inhibitors prevent neuronal cell death and ameliorate motor disturbances after compression-induced spinal cord injury in rats. J Neurotrauma. 2005 Mar;22 (3) :398-406.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
NBP3-13798-20ug 20 µg
Mouse Monoclonal NOC4L Antibody (PCRP-NOC4L-1B2)
Sign In for Pricing
View Details 